HK1206731A1 - Method for preparing substituted triazolopyridines - Google Patents

Method for preparing substituted triazolopyridines Download PDF

Info

Publication number
HK1206731A1
HK1206731A1 HK15107242.4A HK15107242A HK1206731A1 HK 1206731 A1 HK1206731 A1 HK 1206731A1 HK 15107242 A HK15107242 A HK 15107242A HK 1206731 A1 HK1206731 A1 HK 1206731A1
Authority
HK
Hong Kong
Prior art keywords
amino
phenyl
triazolo
pyridin
fluorophenyl
Prior art date
Application number
HK15107242.4A
Other languages
English (en)
Chinese (zh)
Inventor
Volker Schulze
Franz-Josef Mais
Original Assignee
Bayer Pharma Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma Aktiengesellschaft filed Critical Bayer Pharma Aktiengesellschaft
Publication of HK1206731A1 publication Critical patent/HK1206731A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK15107242.4A 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines HK1206731A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP12175640.7 2012-07-10
EP12175640 2012-07-10
EP12185590 2012-09-24
EP12185590.2 2012-09-24
EP13170585.7 2013-06-05
EP13170585 2013-06-05
PCT/EP2013/064017 WO2014009219A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Publications (1)

Publication Number Publication Date
HK1206731A1 true HK1206731A1 (en) 2016-01-15

Family

ID=48793197

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107242.4A HK1206731A1 (en) 2012-07-10 2013-07-03 Method for preparing substituted triazolopyridines

Country Status (24)

Country Link
US (1) US9388177B2 (en:Method)
EP (1) EP2872506A1 (en:Method)
JP (1) JP6238979B2 (en:Method)
KR (1) KR20150040845A (en:Method)
CN (1) CN104603136B (en:Method)
AP (1) AP3778A (en:Method)
AU (1) AU2013289381A1 (en:Method)
BR (1) BR112015000308A2 (en:Method)
CA (1) CA2878481A1 (en:Method)
CL (1) CL2015000038A1 (en:Method)
CO (1) CO7160002A2 (en:Method)
CR (1) CR20150006A (en:Method)
DO (1) DOP2015000007A (en:Method)
EA (1) EA027544B1 (en:Method)
HK (1) HK1206731A1 (en:Method)
IL (1) IL236265A (en:Method)
IN (1) IN2015DN00085A (en:Method)
MX (1) MX2015000348A (en:Method)
NZ (1) NZ703020A (en:Method)
PE (1) PE20150354A1 (en:Method)
PH (1) PH12015500061A1 (en:Method)
SG (1) SG11201408419QA (en:Method)
TN (1) TN2015000008A1 (en:Method)
WO (1) WO2014009219A1 (en:Method)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2914521A1 (en) * 2013-06-07 2014-12-11 Bayer Pharma Aktiengesellschaft Substituted triazolopyridines having activity as mps-1 inhibitors
PL3008062T3 (pl) * 2013-06-11 2017-08-31 Bayer Pharma Aktiengesellschaft Pochodne proleki podstawionych triazolopirydyn
EP3007692A1 (en) 2013-06-11 2016-04-20 Bayer Pharma Aktiengesellschaft Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor
KR102720422B1 (ko) 2015-04-17 2024-10-22 크로스파이어 온콜로지 홀딩 비.브이. Ttk 억제제 화학요법을 위한 예후 바이오마커
TW201800408A (zh) 2016-06-15 2018-01-01 拜耳製藥公司 Mps-1抑制劑

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2003030937A1 (ja) * 2001-10-05 2005-01-20 小野薬品工業株式会社 ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
JP2007537296A (ja) * 2004-05-14 2007-12-20 アボット・ラボラトリーズ 治療薬としてのキナーゼ阻害薬
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
CA2582482A1 (en) * 2004-10-07 2006-04-13 Warner-Lambert Company Llc Triazolopyridine derivatives as antibacterial agents
US20060194823A1 (en) * 2004-12-22 2006-08-31 Georg Kettschau Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
TW200808802A (en) * 2006-06-06 2008-02-16 Schering Corp Imidazopyrazines as protein kinase inhibitors
EP1870416A1 (en) * 2006-06-21 2007-12-26 Bayer Schering Pharma Aktiengesellschaft Sulphonamido-macrocycles as tie2 inhibitors
US8883820B2 (en) 2006-08-30 2014-11-11 Cellzome Ltd. Triazole derivatives as kinase inhibitors
JO3598B1 (ar) * 2006-10-10 2020-07-05 Infinity Discovery Inc الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
WO2009010530A1 (en) 2007-07-18 2009-01-22 Novartis Ag Bicyclic heteroaryl compounds and their use as kinase inhibitors
NZ584138A (en) 2007-08-23 2011-10-28 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
MX2010002312A (es) 2007-08-31 2010-03-18 Merck Serono Sa Compuestos de triazolopiridina y su uso como inhibidores de cinasa reguladora de señal de apoptosis.
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
GB0724342D0 (en) * 2007-12-13 2008-01-30 Prolysis Ltd Anitbacterial compositions
US8530689B2 (en) * 2008-05-05 2013-09-10 The Trustees Of The University Of Pennsylvania Processes for the preparation of biphenyl compounds
WO2009155527A2 (en) * 2008-06-19 2009-12-23 Progenics Pharmaceuticals, Inc. Phosphatidylinositol 3 kinase inhibitors
NZ594508A (en) 2009-02-13 2013-12-20 Fovea Pharmaceuticals [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
CA2760077A1 (en) 2009-04-29 2010-11-04 Marcus Koppitz Substituted imidazoquinoxalines
JP5684245B2 (ja) * 2009-06-05 2015-03-11 セファロン、インク. 1,2,4−トリアゾロ[1,5a]ピリジン誘導体の調製および使用
WO2010141360A1 (en) * 2009-06-05 2010-12-09 Merck Sharp & Dohme Corp. Biaryl benzotriazole derivatives
EP2473498A1 (en) 2009-09-04 2012-07-11 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
EP2343295A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridine derivates
EP2343294A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Substituted triazolopyridines
UY33452A (es) * 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
WO2012044567A2 (en) * 2010-09-30 2012-04-05 Merck Sharp & Dohme Corp. Imidazole derivatives
DK2699575T3 (da) * 2011-04-21 2015-06-22 Bayer Ip Gmbh Triazolopyridiner
WO2012160029A1 (en) * 2011-05-23 2012-11-29 Bayer Intellectual Property Gmbh Substituted triazolopyridines
UA112096C2 (uk) * 2011-12-12 2016-07-25 Байєр Інтеллектуал Проперті Гмбх Заміщені триазолопіридини та їх застосування як інгібіторів ttk

Also Published As

Publication number Publication date
DOP2015000007A (es) 2015-02-15
CL2015000038A1 (es) 2015-03-13
EA201590116A1 (ru) 2015-07-30
AU2013289381A1 (en) 2015-01-22
IL236265A0 (en) 2015-02-26
PE20150354A1 (es) 2015-03-21
CN104603136A (zh) 2015-05-06
WO2014009219A1 (en) 2014-01-16
CR20150006A (es) 2015-02-16
NZ703020A (en) 2017-08-25
JP6238979B2 (ja) 2017-11-29
BR112015000308A2 (pt) 2017-06-27
US9388177B2 (en) 2016-07-12
CN104603136B (zh) 2017-06-27
JP2015523372A (ja) 2015-08-13
IN2015DN00085A (en:Method) 2015-05-29
EA027544B1 (ru) 2017-08-31
MX2015000348A (es) 2015-04-14
AP2014008177A0 (en) 2014-12-31
SG11201408419QA (en) 2015-01-29
IL236265A (en) 2017-07-31
CO7160002A2 (es) 2015-01-15
CA2878481A1 (en) 2014-01-16
EP2872506A1 (en) 2015-05-20
PH12015500061A1 (en) 2015-03-02
US20150148542A1 (en) 2015-05-28
KR20150040845A (ko) 2015-04-15
TN2015000008A1 (en) 2016-06-29
AP3778A (en) 2016-08-31

Similar Documents

Publication Publication Date Title
EP2791136B1 (en) Substituted triazolopyridines and their use as ttk inhibitors
EA023766B1 (ru) Триазолопиридины
KR20220042293A (ko) 질소 함유 다환 축합 고리계 화합물, 이의 약학 조성물, 제조 방법 및 용도
JP6238979B2 (ja) 置換トリアゾロピリジンを調製する方法
EP3008062B1 (en) Prodrug derivatives of substituted triazolopyridines
JP2016527193A (ja) 置換トリアゾロピリジン
EP3004092B1 (en) Substituted triazolopyridines
HK1203200B (en) Substituted triazolopyridines and their use as ttk inhibitors
HK1222652B (en) Substituted triazolopyridines
HK1182708A (en) Substituted triazolopyridines
HK1234732A1 (en) Novel compounds